MDT

85.79

-1.48%↓

A

112.06

+1.49%↑

VEEV

175.19

+1.67%↑

HQY

81.65

-1.05%↓

CSBR

5.56

-0.89%↓

MDT

85.79

-1.48%↓

A

112.06

+1.49%↑

VEEV

175.19

+1.67%↑

HQY

81.65

-1.05%↓

CSBR

5.56

-0.89%↓

MDT

85.79

-1.48%↓

A

112.06

+1.49%↑

VEEV

175.19

+1.67%↑

HQY

81.65

-1.05%↓

CSBR

5.56

-0.89%↓

MDT

85.79

-1.48%↓

A

112.06

+1.49%↑

VEEV

175.19

+1.67%↑

HQY

81.65

-1.05%↓

CSBR

5.56

-0.89%↓

MDT

85.79

-1.48%↓

A

112.06

+1.49%↑

VEEV

175.19

+1.67%↑

HQY

81.65

-1.05%↓

CSBR

5.56

-0.89%↓

Search

Smith & Nephew PLC ADR

Закрыт

31.55 -0.35

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

31.52

Макс.

31.92

Ключевые показатели

By Trading Economics

Доход

35M

331M

Продажи

203M

3.2B

P/E

Средняя по отрасли

22.336

57.05

Дивидендная доходность

2.45

Рентабельность продаж

10.368

Сотрудники

16,988

EBITDA

133M

856M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+10.49% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.45%

2.52%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-1.6B

14B

Предыдущая цена открытия

31.9

Предыдущая цена закрытия

31.55

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

30 мар. 2026 г., 23:15 UTC

Главные новостные события

U.K. Shoppers Paid a Little More This Month But Worse May yet Lie Ahead

30 мар. 2026 г., 22:36 UTC

Главные новостные события

Australian Government Rules Out Boots on the Ground in the Middle East

30 мар. 2026 г., 22:13 UTC

Приобретения, слияния, поглощения

Sun Life Financial Agrees to Buy Bell Partners for $350 Million

30 мар. 2026 г., 21:00 UTC

Отчет

Aktis Oncology Gets FDA Clearance for Phase 1 Billion Trial of Tumor Treatment

30 мар. 2026 г., 20:15 UTC

Главные новостные события

Fed's Williams: Middle-East Developments Have Added Significant Economic Uncertainty

30 мар. 2026 г., 23:40 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

30 мар. 2026 г., 23:40 UTC

Обсуждения рынка

Nikkei May Decline on Higher Energy Cost Concerns -- Market Talk

30 мар. 2026 г., 23:36 UTC

Обсуждения рынка

Gold Edges Lower Amid Divergent Signals on U.S.-Iran Talks -- Market Talk

30 мар. 2026 г., 23:12 UTC

Обсуждения рынка

Alcoa Earnings Outlook Boosted by Market Disruptions -- Market Talk

30 мар. 2026 г., 22:49 UTC

Обсуждения рынка

Fed's Williams: Core Inflation Forecast Is Little Changed -- Market Talk

30 мар. 2026 г., 22:44 UTC

Обсуждения рынка

Fed's Williams: Risks to Both Sides of Dual Mandate Higher -- Market Talk

30 мар. 2026 г., 22:43 UTC

Обсуждения рынка

Fed's Williams Says Focus Is on Inflation Expectations Being Well Anchored -- Market Talk

30 мар. 2026 г., 22:42 UTC

Обсуждения рынка

South32 Should Go for Growth, Says New Bull -- Market Talk

30 мар. 2026 г., 22:18 UTC

Обсуждения рынка

Paragon Care's Chances of Using Levy to Pass on Higher Costs `Close to Zero' -- Market Talk

30 мар. 2026 г., 22:05 UTC

Обсуждения рынка

Northern Star's New Bull Argues Case for Asset Sales -- Market Talk

30 мар. 2026 г., 21:58 UTC

Приобретения, слияния, поглощения

Sun Life Financial Agrees to Buy Bell Partners for $350M

30 мар. 2026 г., 21:39 UTC

Приобретения, слияния, поглощения

Sun Life Sees 1Q Charge to Net of C$236M From BGO, Crescent Deals

30 мар. 2026 г., 21:38 UTC

Приобретения, слияния, поглощения

Sun Life: Completes Remaining Equity Interest Purchases of BGO, Crescent Capital

30 мар. 2026 г., 21:36 UTC

Приобретения, слияния, поглощения

Sun Life to Buy Fully Bell Partners for $350M >SLF.T

30 мар. 2026 г., 21:33 UTC

Приобретения, слияния, поглощения

Unilever Shareholders Expected to Own Two-Thirds of New Food Entity, Sources Say -- WSJ

30 мар. 2026 г., 21:33 UTC

Приобретения, слияния, поглощения

Unilever Nears Deal to Create $60 Billion Food Giant With McCormick -- WSJ

30 мар. 2026 г., 21:33 UTC

Приобретения, слияния, поглощения

Deal Could Be Announced As Soon As Tuesday, Sources Say -- WSJ

30 мар. 2026 г., 21:33 UTC

Приобретения, слияния, поглощения

Unilever Nears Cash-and-Stock Deal to Combine Food Business With McCormick, Sources Say -- WSJ

30 мар. 2026 г., 21:33 UTC

Приобретения, слияния, поглощения

Deal Set to Value Combined Food Business At Around $60B Including Debt, Sources Say -- WSJ

30 мар. 2026 г., 21:25 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

30 мар. 2026 г., 21:25 UTC

Обсуждения рынка

Warehouse Showing Cost Discipline But Margin Goal at Risk -- Market Talk

30 мар. 2026 г., 21:03 UTC

Приобретения, слияния, поглощения

Sun Life: Completes Equity Interest Purchases of BGO and Crescent Cap, Announces Acquisition of Bell Partners, a Multifamily Real Estate Investment Manager

30 мар. 2026 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

30 мар. 2026 г., 20:09 UTC

Отчет

This Stock Looks Like a Solid AI Bet -- and Wall Street Hasn't Noticed Yet -- Barrons.com

30 мар. 2026 г., 20:00 UTC

Главные новостные события

Fed's Williams: Middle-East Conflict 'Will Likely Boost Overall Inflation in Coming Months'

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

10.49% рост

Прогноз на 12 месяцев

Средняя 34.96 USD  10.49%

Максимум 35 USD

Минимум 34.91 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

2 ratings

0

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

26.64 / 28.37Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat